Heilmann H P, Arnal M L, Bünemann H, Calavrezos A, Engel J, Franke H D, Hain E, Jüngst G, Kohl F V, Koschel G, Seysen U, von Wichert P
Strahlentherapie. 1983 Mar;159(3):152-5.
The authors studied the effect of a chemo-/radiotherapy or radio-/chemotherapy on 52 cases of microcellular bronchial carcinoma, classification "limited disease". The survival curves were slightly better for the patients submitted to primary chemotherapy, but the difference was not statistically significant, and the curves coincided again after 18 months. 60 to 80% of the patients had no complaints or only unimportant complaints during more than half of their survival time. In 23 patients with "extensive disease" who received only a symptomatic therapy or a combined palliative chemotherapy, chemotherapy had a slightly better effect, but this was not statistically significant.
作者研究了化疗/放疗或放疗/化疗对52例分类为“局限性疾病”的微细胞支气管癌患者的疗效。接受原发性化疗的患者的生存曲线略好,但差异无统计学意义,且18个月后曲线再次重合。60%至80%的患者在超过一半的生存时间内无不适或仅有轻微不适。在23例接受对症治疗或联合姑息化疗的“广泛性疾病”患者中,化疗效果略好,但无统计学意义。